Back to Search
Start Over
First-line trastuzumab (H), oral vinorelbine (NVBo) and capecitabine (X) combination therapy for HER2-positive metastatic breast cancer (MBC): efficacy and safety in a multinational phase II study.
- Source :
- EJC Supplements; Feb2008, Vol. 6 Issue 7, p220-221, 2p
- Publication Year :
- 2008
Details
- Language :
- English
- ISSN :
- 13596349
- Volume :
- 6
- Issue :
- 7
- Database :
- Supplemental Index
- Journal :
- EJC Supplements
- Publication Type :
- Academic Journal
- Accession number :
- 32054554
- Full Text :
- https://doi.org/10.1016/S1359-6349(08)70894-2